Figures & data
Table 1. Basic information of each group.
Figure 1. Comparison of the expression levels of serum IL-17, TNF-α and DKK-1 in each group, **p < 0.001; *p < 0.05.
![Figure 1. Comparison of the expression levels of serum IL-17, TNF-α and DKK-1 in each group, **p < 0.001; *p < 0.05.](/cms/asset/c5589264-4807-4186-b4f1-7d447155f6e6/iaut_a_2276068_f0001_b.jpg)
Figure 3. Relationship between DAS28 scores and the expression levels of IL-17, TNF-α and DKK-1 in RA.
![Figure 3. Relationship between DAS28 scores and the expression levels of IL-17, TNF-α and DKK-1 in RA.](/cms/asset/1edd9b35-c744-45b0-a153-c95c7a57a2b3/iaut_a_2276068_f0003_b.jpg)
Table 2. Clinical evaluation of research indices.
Figure 5. ROC Curves of IL-17, TNF-α and DKK-1 for the diagnosis of moderate to high activity RA.
Note: ROC, subject operating characteristic curve.
![Figure 5. ROC Curves of IL-17, TNF-α and DKK-1 for the diagnosis of moderate to high activity RA.Note: ROC, subject operating characteristic curve.](/cms/asset/ce34ffc5-feed-4d39-be7c-cd1d246a41e3/iaut_a_2276068_f0005_c.jpg)
Table 3. Clinical evaluation of IL-17, TNF-α and DKK-1 in the diagnosis of moderate to high activity RA.
Data availability statement
The data that support the fundings of this study are availability from the corresponding author [QW], upon reasonable request.